Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;101:1500-1502

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vink, H.
Right arrow Articles by Spaan, J. A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vink, H.
Right arrow Articles by Spaan, J. A. E.
Related Collections
Right arrow Pathophysiology
Right arrow Endothelium/vascular type/nitric oxide

(Circulation. 2000;101:1500.)
© 2000 American Heart Association, Inc.


Brief Rapid Communications

Oxidized Lipoproteins Degrade the Endothelial Surface Layer

Implications for Platelet-Endothelial Cell Adhesion

Hans Vink, PhD; Alina A. Constantinescu, MD; Jos A. E. Spaan, PhD

From the Department of Medical Physics, University of Amsterdam, Amsterdam, The Netherlands.

Correspondence to Hans Vink, PhD, Department of Medical Physics, Academic Medical Center, University of Amsterdam, PO Box 22700, 1100 DE Amsterdam, The Netherlands. E-mail h.vink{at}amc.uva.nl


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background—Flowing erythrocytes and platelets are separated from the luminal endothelial cell (EC) surface by a 0.5-µm-wide space named the endothelial surface layer. We hypothesized that the disruption of the endothelial surface layer by oxidized low-density lipoproteins (Ox-LDL) contributes to atherogenic increases in vascular wall adhesiveness.

Methods and Results—The hamster cremaster muscle preparation was used for intravital microscopic observation of the distance between erythrocytes and the capillary EC surface. Moderate Ox-LDL was prepared by exposing native LDL to CuSO4 for 6 hours. The dimension of the EC surface layer averaged 0.6±0.1 µm during control situations, but a bolus intravenous injection of Ox-LDL (0.4 mg/100 g of body weight) transiently diminished the EC surface layer by 60% within 25 minutes, which correlated with a transient increase in the number of platelet-EC adhesions. Combined administration of superoxide dismutase and catalase completely blocked the effect of Ox-LDL on the dimension of the EC surface layer and inhibited platelet-EC adhesion.

Conclusions—Oxygen-derived free radicals mediate the disruption of the EC surface layer and increase vascular wall adhesiveness by Ox-LDL.


Key Words: atherosclerosis • lipoproteins • endothelium • platelets


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Damage to the endothelial cell (EC) glycocalyx seems to be the earliest detectable injury to the vascular wall during the development of atherosclerosis and is associated with increased vascular permeability and adhesiveness.1 2 Recently, Vink and Duling3 showed that measuring the relative positions of flowing blood cells and the EC membrane in skeletal muscle capillaries provided dimensional information on the in vivo endothelial surface layer, which includes the EC glycocalyx and associated plasma proteins. Moreover, they demonstrated that light-dye–induced generation of oxygen-derived free radicals disrupted the endothelial surface layer, which resulted in localized adhesion of platelets and red blood cells (RBCs) to the vascular wall.3 In the present study, we tested the hypothesis that oxidized low-density lipoproteins (Ox-LDL) modulate the endothelial surface layer in a similar fashion.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Animal Preparation
Male, Golden hamsters (n=19; body weight, 139±7 g) were anesthetized with intraperitoneal pentobarbital sodium (70 mg/kg body weight), and the trachea was cannulated to ensure a patent airway. The left femoral vein was cannulated for the continuous infusion of 0.9% saline (0.5 mL/h) containing 10 mg/mL pentobarbital sodium. The hamster was placed on a plexiglas platter, and the right cremaster muscle was prepared for visualization of the microcirculation as previously described.3 The cremaster muscle was continuously superfused at 5 mL/min with a bicarbonate-buffered physiological salt solution (composition [in mmol/L]: NaCl 131.9, KCl 4.6, CaCl2 2.0, MgSO4 1.2, and NaHCO3 20). The superfusion solution was gas-equilibrated with 5% CO2 and 95% N2 to obtain a pH of 7.35 to 7.45, and the solution was maintained at 34°C. Succinylcholine (10-5 mol/L; Sigma) was added to the superfusion solution to reduce spontaneous skeletal muscle contractions. Body temperature was maintained at 37°C to 38°C with conducted heat. These procedures were performed in accordance with institutional guidelines.

Intravital Microscopy
The cremaster muscle was observed with an intravital microscope (Olympus BHM) and a cooled intensified charge-coupled device video camera (GenIV ICCD, Princeton Instruments). The tissue was transilluminated with a mercury lamp (100 W) equipped with a 435-nm bandpass interference filter (blue light) using an applanate, achromatic condenser set at numerical aperture 1.2 (Universal Applanate Achromatic Condensor, Olympus). All preparations were examined with a x60, water-immersion, objective lens (Olympus, UPlanApo with aperture of 1.2 W or LUMPlanFL with aperture of 0.9 W) and a telescopic tube to give a final object-to-camera magnification of x250. Images were displayed on a Philips CM 8833-II video monitor and recorded using a SVHS videotape recorder (JVC BR-S611E) and a time-coding interface unit (JVC SA-F911E) for further image analysis.

Data Analysis
Video images were digitized using a frame grabber (DT3152, PCI Local Bus) and Image-Pro Plus software (Image-Pro Plus version 3.0, Media Cybernetics). An onscreen caliper using a 1 mm/0.01 mm stage micrometer was used for all calibrated dimensional measurements. The anatomical capillary diameter was estimated by positioning the digital calipers at the inside of the capillary wall. Observed microvessel diameters ranged between 3 and 10 µm, indicating that in addition to true capillary blood vessels, the observed population of microvessels probably included terminal arterioles and/or capillary venules. Platelets that remained stuck to the endothelium for >=2 video frames in the presence of continuously flowing RBCs were counted off-line by slow motion video play back.

Experimental Protocols
All experimental protocols started 45 to 60 minutes after completion of the hamster cremaster preparation. Measurements of capillary dimensions were made starting 10 to 15 minutes before the injection of either native LDL (n=4) or Ox-LDL (n=7) at 0.4 mg/100 g body weight. Human LDL (Sigma, L2139) was dialyzed against PBS for 24 hours at 4°C at pH 7.4 without EDTA. LDL was oxidized by the addition of CuSO4 at a concentration of 7.5 µmol/L for 6 hours at 37°C. This reaction was stopped by the addition of 0.01 mmol/L EDTA; normal LDL was stored for 6 hours at 4°C. Finally, both normal LDL and Ox-LDL were dialyzed for 48 hours in PBS and 0.01% EDTA at 4°C. Protein concentrations were determined using the method of Lowry et al.3A LDL samples were stored at 4°C. Using a measurement of {approx}5 mL of plasma volume in a 100-g hamster, the initial systemic Ox-LDL concentration was estimated as <=0.4 mg/5 mL, or <=8 mg/dL. This measurement seems to be clinically relevant on the basis of recent measurements in atherosclerotic patients; these measurements show Ox-LDL concentrations between 1 and 6 mg/dL.4

To test for the involvement of oxygen-derived free radicals, additional Ox-LDL experiments (n=8) were performed in the presence of superoxide dismutase (SOD) and catalase, as described previously.3

Statistics
Data on the dimension of the spacing between RBCs and the luminal EC membrane (RBC-EC gap) are presented as means±SE. RBC-EC gap values after the injection of either normal LDL or Ox-LDL were compared with their respective controls (preinjection values) using a paired t test (2-way) to test for significance at P<0.05.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
Figure 1Down shows the gap between flowing RBCs and the luminal EC membrane as a measure of the dimension of the endothelial surface layer. The injection of moderate Ox-LDL (Figure 1BDown), but not normal LDL (Figure 1ADown), resulted in a transient decrease of >50% in the distance of flowing blood cells to the endothelial surface, which could be completely blocked by the administration of SOD and catalase (Figure 1CDown). Numbers of adhering platelets counted in 10-minute intervals are depicted on the time axis. Only 1 platelet was seen adhering spontaneously to the EC surface in a total of 4 experiments after the injection of normal LDL. In contrast, in 7 of 7 Ox-LDL experiments, >=1 platelet was seen sticking to the endothelium, giving a total of 15 platelet-EC adhesions in 7 experiments with Ox-LDL. No adhering platelets were observed in the presence of SOD and catalase. Figure 2Down depicts examples of the transient decrease in RBC-EC gap dimensions at 0, 24, and 70 minutes after bolus injection of Ox-LDL.



View larger version (18K):
[in this window]
[in a new window]
 
Figure 1. Dimension of gap between flowing RBCs and luminal EC membrane as a measure of dimension of endothelial surface layer, before and after injection of either normal LDL (A), Ox-LDL (B), or Ox-LDL together with SOD and catalase (C). Platelets observed to adhere to EC surface within 10-minute intervals are depicted on time axis as spheres. *Significantly different (P<0.05) from value before injection of Ox-LDL.



View larger version (61K):
[in this window]
[in a new window]
 
Figure 2. Examples of light microscopic images of RBCs flowing through a hamster cremaster muscle capillary during an Ox-LDL experiment, showing gap between flowing RBCs and luminal EC membrane. A, B, and C show transient decrease in RBC-EC gap dimension at 0, 24, and 70 minutes, respectively, after bolus injection of Ox-LDL. Calibration bar in A represents 2 µm.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
Although early electron microscopic studies revealed decades ago that carbohydrate-rich endothelial surface structures form the interface between blood and the luminal endothelial membrane,5 relatively few studies have attempted to associate a modulation of EC function with a modification of the endothelial surface layer, which is defined as the EC glycocalyx and associated plasma proteins.

Treating the RBC surface charge with polycations6 or enzymatically treating the endothelial surface layer7 8 modulates RBC flow through capillary blood vessels and stimulates platelet-EC adhesion. Studies on transvascular exchange demonstrated that the adsorption of albumin and other plasma proteins to the EC glycocalyx confers filter-like properties to the endothelial surface layer and reduces microvascular hydraulic conductivity and solute permeability.9 10 11 Enzymatic disruption of the EC glycocalyx increased the adhesion of blood cells to the vascular wall8 and abolished flow-dependent dilation due to impaired endothelial production of nitric oxide.12 13 These studies demonstrate that the endothelial surface layer is essential for several aspects of endothelial function, including the control of transvascular exchange, providing vessels with an anti-adhesive inner lining, and flow-dependent dilation.

In the present study, we used a recently developed light microscopic technique3 to demonstrate for the first time that a clinically relevant dose of Ox-LDL4 reduces the in vivo dimension of the endothelial surface layer and simultaneously increases platelet-EC adhesion. These effects were completely inhibited by the administration of SOD and catalase, indicating that increased amounts of oxygen-derived free radicals mediate Ox-LDL–induced degradation of the endothelial surface layer and the consequent loss of endothelial anti-adhesive properties. Similarly, Lehr et al14 demonstrated that the increased adhesion of leukocytes to the endothelium of small arterioles and venules after the systemic bolus injection of Ox-LDL could be prevented by vitamin C or SOD. Furthermore, Liao and Granger15 showed that SOD prevented Ox-LDL–induced albumin leakage and leukocyte adhesion to the vascular endothelium.

Oxygen-derived free radicals such as the superoxide anion may degrade the endothelial surface layer and induce the adhesion of platelets by inactivating paracrine anti-platelet substances, such as nitric oxide. Alternatively, oxygen radicals may have unmasked constitutive endothelial adhesion molecules, such as platelet-endothelial cell adhesion molecule, by removing glycocalyx-associated plasma proteins from the EC surface. Readsorption of plasma substances to the EC glycocalyx might then explain the rapid recovery of the endothelial surface layer after its disruption by a bolus injection of Ox-LDL. In agreement with this possibility, our reported layer recovery time (20 to 30 minutes) agrees well with published data on plasma protein reconstitution of the EC surface layer after vascular perfusion with a protein-poor medium.16 However, reconstitution of the EC surface layer by newly synthesized or preformed proteoglycans and/or glycosaminoglycans must also be considered, and additional studies must be designed to distinguish between these mechanisms of surface layer repair.


*    Acknowledgments
 
Dr Vink was supported by the Netherlands Organization for Scientific Research (NWO 902–16-205).

Received October 12, 1999; revision received April 4, 2000; accepted April 8, 2000.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 
1. Haldenby KA, Chappell DC, Winlove CP, Parker KH, Firth JA. Focal and regional variations in the composition of the glycocalyx of large vessel endothelium. J Vasc Res. 1994;31:2–9.[Medline] [Order article via Infotrieve]

2. Gorog P, Born GV. Uneven distribution of sialic acids on the luminal surface of aortic endothelium. Br J Exp Pathol. 1983;64:418–424.[Medline] [Order article via Infotrieve]

3. Vink H, Duling BR. Identification of distinct luminal domains for macromolecules, erythrocytes, and leukocytes within mammalian capillaries. Circ Res. 1996;79:581–589.[Abstract/Free Full Text]

3. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem.. 1951;193:265–275.[Free Full Text]

4. Holvoet P, Vanhaecke J, Janssens S, Vandewerf F, Collen D. Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation. 1998;98:1487–1494.[Abstract/Free Full Text]

5. Luft JH. Fine structures of capillary and endocapillary layer as revealed by ruthenium red. Fed Proc. 1966;25:1773–1783.[Medline] [Order article via Infotrieve]

6. Vink H, Wieringa PA, Spaan JAE. Evidence that cell surface charge reduction modifies capillary red cell velocity-flux relationships in hamster cremaster muscle. J Physiol (Lond). 1995;489:193–201.[Abstract/Free Full Text]

7. Desjardins C, Duling BR. Heparinase treatment suggests a role for the endothelial cell glycocalyx in regulation of capillary hematocrit. Am J Physiol. 1990;258:H647–H654.[Medline] [Order article via Infotrieve]

8. Pries AR, Secomb TW, Jacobs H, Sperandio M, Osterloh K, Gaehtgens P. Microvascular blood flow resistance: role of endothelial surface layer. Am J Physiol. 1997;42:H2272–H2279.

9. Clough G. Relationship between microvascular permeability and ultrastructure. Prog Biophys Mol Biol. 1991;55:47–69.[Medline] [Order article via Infotrieve]

10. Michel CC, Phillips ME. The effects of bovine serum albumin and a form of cationised ferritin upon the molecular selectivity of the walls of single frog capillaries. Microvasc Res. 1985;29:190–203.[Medline] [Order article via Infotrieve]

11. Huxley VH, Curry FE, Powers MR, Thipakorn B. Differential action of plasma and albumin on transcapillary exchange of anionic solute. Am J Physiol. 1993;264:H1428–H1437.[Medline] [Order article via Infotrieve]

12. Pohl U, Herlan K, Huang A, Bassenge E. Edrf-mediated shear-induced dilation opposes myogenic vasoconstriction in small rabbit arteries. Am J Physiol. 1991;261:H2016–H2023.[Medline] [Order article via Infotrieve]

13. Hecker M, Mülsch A, Bassenge E, Busse R. Vasoconstriction and increased flow: two principal mechanisms of shear stress-dependent endothelial autacoid release. Am J Physiol. 1993;265:H828–H833.[Medline] [Order article via Infotrieve]

14. Lehr HA, Seemuller J, Hubner C, Menger MD, Messmer K. Oxidized LDL-induced leukocyte/endothelium interaction in vivo involves the receptor for platelet-activating factor. Arterioscler Thromb. 1993;13:1013–1018.[Abstract/Free Full Text]

15. Liao L, Granger DN. Modulation of oxidized low-density lipoprotein-induced microvascular dysfunction by nitric oxide. Am J Physiol. 1995;268:H1643–H650.[Medline] [Order article via Infotrieve]

16. Schneeberger EE, Hamelin M. Interaction of serum proteins with lung endothelial glycocalyx: its effects on endothelial permeability. Am J Physiol. 1984;247:H206–H217.[Medline] [Order article via Infotrieve]




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
S. Devaraj, J.-M. Yun, G. Adamson, J. Galvez, and I. Jialal
C-reactive protein impairs the endothelial glycocalyx resulting in endothelial dysfunction
Cardiovasc Res, December 1, 2009; 84(3): 479 - 484.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
D. Chappell, M. Jacob, O. Paul, M. Rehm, U. Welsch, M. Stoeckelhuber, P. Conzen, and B. F. Becker
The Glycocalyx of the Human Umbilical Vein Endothelial Cell: An Impressive Structure Ex Vivo but Not in Culture
Circ. Res., June 5, 2009; 104(11): 1313 - 1317.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. C. Meuwese, H. L. Mooij, M. Nieuwdorp, B. van Lith, R. Marck, H. Vink, J. J. P. Kastelein, and E. S. G. Stroes
Partial recovery of the endothelial glycocalyx upon rosuvastatin therapy in patients with heterozygous familial hypercholesterolemia
J. Lipid Res., January 1, 2009; 50(1): 148 - 153.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
G. B. Kowalsky, F. J. Byfield, and I. Levitan
oxLDL facilitates flow-induced realignment of aortic endothelial cells
Am J Physiol Cell Physiol, August 1, 2008; 295(2): C332 - C340.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
M.I.M. Noble, A.J. Drake-Holland, and H. Vink
Hypothesis: arterial glycocalyx dysfunction is the first step in the atherothrombotic process
QJM, July 1, 2008; 101(7): 513 - 518.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. W. G. E. VanTeeffelen, A. A. Constantinescu, J. Brands, J. A. E. Spaan, and H. Vink
Bradykinin- and sodium nitroprusside-induced increases in capillary tube haematocrit in mouse cremaster muscle are associated with impaired glycocalyx barrier properties
J. Physiol., July 1, 2008; 586(13): 3207 - 3218.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. Nieuwdorp, M. C. Meuwese, H. L. Mooij, C. Ince, L. N. Broekhuizen, J. J. P. Kastelein, E. S. G. Stroes, and H. Vink
Measuring endothelial glycocalyx dimensions in humans: a potential novel tool to monitor vascular vulnerability
J Appl Physiol, March 1, 2008; 104(3): 845 - 852.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
M. Schouten, W. J. Wiersinga, M. Levi, and T. van der Poll
Inflammation, endothelium, and coagulation in sepsis
J. Leukoc. Biol., March 1, 2008; 83(3): 536 - 545.
[Abstract] [Full Text] [PDF]


Home page
haematolHome page
E. J. van Beers, M. Nieuwdorp, A. J. Duits, L. M. Evers, J.-J. B. Schnog, B. J. Biemond, and on behalf of the CURAMA study group
Sickle cell patients are characterized by a reduced glycocalyx volume
Haematologica, February 1, 2008; 93(2): 307 - 308.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Rehm, D. Bruegger, F. Christ, P. Conzen, M. Thiel, M. Jacob, D. Chappell, M. Stoeckelhuber, U. Welsch, B. Reichart, et al.
Shedding of the Endothelial Glycocalyx in Patients Undergoing Major Vascular Surgery With Global and Regional Ischemia
Circulation, October 23, 2007; 116(17): 1896 - 1906.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
B. van den Berg and H. Vink
Glycocalyx perturbation: cause or consequence of damage to the vasculature?
Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2174 - H2175.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. Rubio-Gayosso, S. H. Platts, and B. R. Duling
Reactive oxygen species mediate modification of glycocalyx during ischemia-reperfusion injury
Am J Physiol Heart Circ Physiol, June 1, 2006; 290(6): H2247 - H2256.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
R. Kelly, T. Ruane-O'Hora, M. I. M. Noble, A. J. Drake-Holland, and H. M. Snow
Differential inhibition by hyperglycaemia of shear stress- but not acetylcholine-mediated dilatation in the iliac artery of the anaesthetized pig
J. Physiol., May 15, 2006; 573(1): 133 - 145.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A. A. Elesber, H. Solomon, R. J. Lennon, V. Mathew, A. Prasad, G. Pumper, R. E. Nelson, J. P. McConnell, L. O. Lerman, and A. Lerman
Coronary endothelial dysfunction is associated with erectile dysfunction and elevated asymmetric dimethylarginine in patients with early atherosclerosis
Eur. Heart J., April 1, 2006; 27(7): 824 - 831.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Nieuwdorp, T. W. van Haeften, M. C.L.G. Gouverneur, H. L. Mooij, M. H.P. van Lieshout, M. Levi, J. C.M. Meijers, F. Holleman, J. B.L. Hoekstra, H. Vink, et al.
Loss of Endothelial Glycocalyx During Acute Hyperglycemia Coincides With Endothelial Dysfunction and Coagulation Activation In Vivo
Diabetes, February 1, 2006; 55(2): 480 - 486.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Gouverneur, J. A. E. Spaan, H. Pannekoek, R. D. Fontijn, and H. Vink
Fluid shear stress stimulates incorporation of hyaluronan into endothelial cell glycocalyx
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H458 - H452.
[Abstract] [Full Text] [PDF]


Home page
Br J OphthalmolHome page
A Grosso, F Veglio, M Porta, F M Grignolo, and T Y Wong
Hypertensive retinopathy revisited: some answers, more questions
Br J Ophthalmol, December 1, 2005; 89(12): 1646 - 1654.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. M. A. van Haaren, E. VanBavel, H. Vink, and J. A. E. Spaan
Charge modification of the endothelial surface layer modulates the permeability barrier of isolated rat mesenteric small arteries
Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2503 - H2507.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. W. G. E. VanTeeffelen, S. Dekker, D. S. Fokkema, M. Siebes, H. Vink, and J. A. E. Spaan
Hyaluronidase treatment of coronary glycocalyx increases reactive hyperemia but not adenosine hyperemia in dog hearts
Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2508 - H2513.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. R. Pries and T. W. Secomb
Microvascular blood viscosity in vivo and the endothelial surface layer
Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2657 - H2664.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Bruegger, M. Jacob, M. Rehm, M. Loetsch, U. Welsch, P. Conzen, and B. F. Becker
Atrial natriuretic peptide induces shedding of endothelial glycocalyx in coronary vascular bed of guinea pig hearts
Am J Physiol Heart Circ Physiol, November 1, 2005; 289(5): H1993 - H1999.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
C. J. Zuurbier, C. Demirci, A. Koeman, H. Vink, and C. Ince
Short-term hyperglycemia increases endothelial glycocalyx permeability and acutely decreases lineal density of capillaries with flowing red blood cells
J Appl Physiol, October 1, 2005; 99(4): 1471 - 1476.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Kiyooka, O. Hiramatsu, F. Shigeto, H. Nakamoto, H. Tachibana, T. Yada, Y. Ogasawara, M. Kajiya, T. Morimoto, Y. Morizane, et al.
Direct observation of epicardial coronary capillary hemodynamics during reactive hyperemia and during adenosine administration by intravital video microscopy
Am J Physiol Heart Circ Physiol, March 1, 2005; 288(3): H1437 - H1443.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
F. Krotz, H.-Y. Sohn, and U. Pohl
Reactive Oxygen Species: Players in the Platelet Game
Arterioscler Thromb Vasc Biol, November 1, 2004; 24(11): 1988 - 1996.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. G. Coleman Jr, R. K. Polanowska-Grabowska, M. Marcinkiewicz, and A. R. L. Gear
LDL oxidized by hypochlorous acid causes irreversible platelet aggregation when combined with low levels of ADP, thrombin, epinephrine, or macrophage-derived chemokine (CCL22)
Blood, July 15, 2004; 104(2): 380 - 389.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
M. K. Ikram, F. J. de Jong, J. R. Vingerling, J. C. M. Witteman, A. Hofman, M. M. B. Breteler, and P. T. V. M. de Jong
Are Retinal Arteriolar or Venular Diameters Associated with Markers for Cardiovascular Disorders? The Rotterdam Study
Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2129 - 2134.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
S. H. Platts and B. R. Duling
Adenosine A3 Receptor Activation Modulates the Capillary Endothelial Glycocalyx
Circ. Res., January 9, 2004; 94(1): 77 - 82.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. M. A. van Haaren, E. VanBavel, H. Vink, and J. A. E. Spaan
Localization of the permeability barrier to solutes in isolated arteries by confocal microscopy
Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2848 - H2856.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
R. T. Hurst and R. W. Lee
Increased Incidence of Coronary Atherosclerosis in Type 2 Diabetes Mellitus: Mechanisms and Management
Ann Intern Med, November 18, 2003; 139(10): 824 - 834.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. A. Constantinescu, H. Vink, and J. A.E. Spaan
Endothelial Cell Glycocalyx Modulates Immobilization of Leukocytes at the Endothelial Surface
Arterioscler Thromb Vasc Biol, September 1, 2003; 23(9): 1541 - 1547.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. Mochizuki, H. Vink, O. Hiramatsu, T. Kajita, F. Shigeto, J. A. E. Spaan, and F. Kajiya
Role of hyaluronic acid glycosaminoglycans in shear-induced endothelium-derived nitric oxide release
Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H722 - H726.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. H. Platts, J. Linden, and B. R. Duling
Rapid modification of the glycocalyx caused by ischemia-reperfusion is inhibited by adenosine A2A receptor activation
Am J Physiol Heart Circ Physiol, June 1, 2003; 284(6): H2360 - H2367.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
B. M. van den Berg, H. Vink, and J. A.E. Spaan
The Endothelial Glycocalyx Protects Against Myocardial Edema
Circ. Res., April 4, 2003; 92(6): 592 - 594.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Tailor and D. N. Granger
Hypercholesterolemia Promotes P-Selectin-Dependent Platelet-Endothelial Cell Adhesion in Postcapillary Venules
Arterioscler Thromb Vasc Biol, April 1, 2003; 23(4): 675 - 680.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. A. Constantinescu, H. Vink, and J. A. E. Spaan
Elevated capillary tube hematocrit reflects degradation of endothelial cell glycocalyx by oxidized LDL
Am J Physiol Heart Circ Physiol, March 1, 2001; 280(3): H1051 - H1057.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vink, H.
Right arrow Articles by Spaan, J. A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vink, H.
Right arrow Articles by Spaan, J. A. E.
Related Collections
Right arrow Pathophysiology
Right arrow Endothelium/vascular type/nitric oxide